Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Xyrem
Pharma
Jazz Pharma, focused on launches, reveals some exec changes
As Jazz turns the page from its long-time growth driver Xyrem, its executive roster is undergoing some changes.
Zoey Becker
Sep 12, 2023 1:55pm
FDA faces lawsuit from Jazz after approval of Avadel's sleep aid
Jun 23, 2023 11:38am
The top 10 drug patent expirations of 2023
Mar 13, 2023 3:00am
In Jazz case, FTC urges court to delist patent on Xyrem
Nov 14, 2022 9:40am
Avadel gets tentative FDA nod for rival to Jazz narcolepsy drug
Jul 26, 2022 7:50am
FDA nod strengthens Jazz's hold of sleep disorder market
Aug 13, 2021 11:08am
